FDA Inspection 1283772 — Blood Center (The)

Blood Center (The) — FEI 3006611631

The FDA completed an inspection of Blood Center (The) on September 3, 2025 in New Orleans, LA. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Biologics.

Inspection Details

Classification
No Action Indicated (NAI) (NAI)
End Date
September 3, 2025
Fiscal Year
2025
Product Type
Biologics
Project Area
Blood and Blood Products
Location
New Orleans, LA (United States)